Pelabresib: Clinical Trials

1 trial of Pelabresib, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Completed 1

Follow Pelabresib: new trials by email Literature Review of Pelabresib trials Research Report on Pelabresib

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase 1/2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Hematologic and Myeloproliferative Malignancies
Pelabresib, Ruxolitinib - Myelofibrosis, Leukemia, Myelocytic, Acute
Phase 1 / Phase 2CompletedConstellation Pharmaceuticals3362014-07-162026-06-04

Conditions studied

Bone Marrow Diseases (1)  ·  Hematologic Diseases (1)  ·  Leukemia (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Myelodysplastic Syndromes (1)  ·  Myelodysplastic-Myeloproliferative Diseases (1)  ·  Myeloproliferative Disorders (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Precancerous Conditions (1)  ·  Preleukemia (1)  ·  Primary Myelofibrosis (1)  ·  Thrombocythemia, Essential (1)

Sponsors

Constellation Pharmaceuticals (1)

Countries

Belgium (1)  ·  Canada (1)  ·  France (1)  ·  Germany (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Poland (1)  ·  United Kingdom (1)  ·  United States (1)

Results publications

PMID 36881782, PMID 37530627, PMID 38259250

NIH funding

2018 (1)